Clinical trials in neonatal sepsis

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2733-2745

  Oeser, Clarissa ^a   Lutsar, Irja ^b   Metsvaht, Tuuli ^c   Turner, Mark A ^d   Heath, Paul T ^a   Sharland, Mike ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF TARTU   (Estonia)

^c TARTU UNIVERSITY CLINICS   (Estonia)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antibiotics; Endpoints; Infants; Methodology

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW DISEASE; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LABORATORY TEST; LIVER DISEASE; MICROBIOLOGICAL PARAMETERS; NEWBORN SEPSIS; PHARMACODYNAMICS; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOPHLEBITIS; VOMITING;

ANTIBIOTICS; ENDPOINTS; INFANTS; METHODOLOGY;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; HUMANS; INFANT, NEWBORN; SEPSIS; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 84887566978     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt297     Document Type: Article

References (45)

1. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis 2008; 21: 223-7.
2. Wirtschafter DD, Padilla G, Suh O et al. Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: an exploratory critique. J Perinatol 2011; 31: 514-8.
3. Sharland M, Cant A, Shingadia S. Manual of Childhood Infections: The Blue Book. Oxford: Oxford University Press, 2011.
4. Paediatric Formulary Committee. BNF for Children 2011-2012. London: BMJ Group, Pharmaceutical Press and RCPCH Publications, 2011.
5. NeoFax. Montvale, NJ: Thomson Reuters, 2011.
6. Lutsar I, Trafojer UM, Heath PT et al. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials 2011; 12: 215.
7. Gordon A, Jeffery HE. Antibiotic regimens for suspected late onset sepsis in newborn infants. Cochrane Database Syst Rev 2005; issue 3: CD004501.
8. Mtitimila EI, Cooke RW. Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database Syst Rev 2004; issue 4: CD004495.
9. Metsvaht T, Ilmoja ML, Parm U et al. Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis. Acta Paediatr 2010; 99: 665-72.
10. Begue P, Michel B, Chasalette JP et al. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants]. Pathol Biol (Paris) 1986; 34: 525-9.
11. Adelman RD, Wirth F, Rubio T. A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate. J Pediatr 1987; 111: 888-93.
12. Adelman RD, Wirth F, Rubio T. A controlled study of the nephrotoxicity of mezlocillin and amikacin in the neonate.AmJ Dis Child 1987; 141: 1175-8.
13. Wiese G. Treatmentofneonatal sepsis with ceftriaxone/gentamicinand with azlocillin/gentamicin: a clinical comparison of efficacy and tolerability. Chemotherapy 1988; 34: 158-63.
14. Fowlie PW, Tarnow-Mordi WO,Gould CR et al. Predicting outcome in very low birthweight infants using an objective measure of illness severity and cranial ultrasound scanning. Arch Dis Child Fetal Neonatal Ed 1998; 78: F175-8.
15. Mahieu LM, De Dooy JJ, Cossey VR et al. Internal and external validation of the NOSEP prediction score for nosocomial sepsis in neonates. Crit Care Med 2002; 30: 1459-66.
16. Clinical prediction of serious bacterial infections in young infants in developing countries. WHO Young Infants Study Group. Pediatr Infect Dis J 1999; 18: S23-31.
17. Richardson DK, Gray JE, McCormick MC et al. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993; 91: 617-23.
18. Janota J, Simak J, Stranak Z et al. Critically ill newborns with multiple organ dysfunction: assessment by NEOMOD score in a tertiary NICU. Ir J Med Sci 2008; 177: 11-7.
19. Goldstein B, Giroir B, Randolph A. International Pediatric Sepsis Consensus Conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2-8.
20. Fanaroff AA, Korones SB, Wright LL et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17: 593-8.
21. Odio CM, Umana MA, Saenz A et al. Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia. Pediatr Infect Dis J 1987; 6: 371-7.
22. Umana MA, Odio CM, Castro E et al. Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. Pediatr Infect Dis J 1990; 9: 175-80.
23. Gokalp AS, Oguz A, Gultekin A et al. Neonatal sepsis in Turkey: the comparison between penicillin plus aminoglycoside and ampicillin plus third-generation cephalosporin chemotherapies. Mater Med Pol 1991; 23: 226-8.
24. Hall MA, Ducker DA, Lowes JA et al. A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis. Drugs 1988; 35 Suppl 2: 169-77.
25. Marks S, Marks MI, Dupont C et al. Evaluation of three antibiotic programs in newborn infants. Can Med Assoc J 1978; 118: 659-62.
26. Nelson JD, McCracken GH Jr. Clinical pharmacology of carbenicillin and gentamicin in the neonate and comparative efficacy with ampicillin and gentamicin. Pediatrics 1973; 52: 801-12.
27. Snelling S, Hart CA, Cooke RW. Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old. J Antimicrob Chemother 1983; 12 Suppl A: 353-6.
28. Pammi M, Flores A, LeeflangMet al. Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis. Pediatrics 2011; 128: e973-85.
29. Fogel D, Farfel L, Miskin A et al. Comparison between the combination of azlocillin-gentamicin and ampicillin-gentamicin in the treatment of a nursery population. Isr J Med Sci 1983; 19: 1009-15.
30. Pacifici GM. Pharmacokinetics of cephalosporins in the neonate: a review. Clinics (Sao Paulo) 2011; 66: 1267-74.
31. Pacifici GM. Clinical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol 2009; 65: 419-27.
32. Pacifici GM, Labatia J, Mulla H et al. Clinical pharmacokinetics of penicillins in the neonate: a review of the literature. Eur J Clin Pharmacol 2009; 65: 191-8.
33. de Louvois J, Dagan R, Tessin I. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases-Neonatal Sepsis Study Group. Eur J Pediatr 1992; 151: 876-84.
34. Vergnano S, Menson E, Kennea N et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96: F9-14.
35. Miall-Allen VM, Whitelaw AG, Darrell JH. Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections. Br J Clin Pract 1988; 42: 273-9.
36. Hammerberg O, Kurnitzki C, Watts J et al. Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis. Eur J Clin Microbiol Infect Dis 1989; 8: 241-4.
37. CHMP. Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. In: Agency EM, ed. London: European Union, 2011.
38. Natesan M, Ulrich RG. Protein microarrays and biomarkers of infectious disease. Int J Mol Sci 2010; 11: 5165-83.
39. Ghazal P, Dickinson P, Smith CL. Early life response to infection. Curr Opin Infect Dis 2013; 26: 213-8.
40. Bonate PL. Recommended reading in population pharmacokinetic pharmacodynamics. AAPS J 2005; 7: E363-73.
41. van den Anker J. Use of aminoglycosides in preterm neonates: a simple task? J Pediatr 2009; 154: 935.
42. Barker CI, Standing JF, Turner MA et al. Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/ pharmacodynamic studies2and when is enough data enough? Curr Opin Infect Dis 2012; 25: 235-42.
43. Haffejee IE. A therapeutic trial of cefotaxime versus penicillingentamicin for severe infections in children. J Antimicrob Chemother 1984; 14 Suppl B: 147-52.
44. Tessin I, Trollfors B, Thiringer K et al. Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants. Eur J Pediatr 1989; 148: 679-81.
45. Gokalp AS, Oguz A. Neonatal sepsis in Turkey: the comparison between penicillin plus aminoglycoside and ampicillin plus third-generation cephalosporin chemotherapies. J Trop Pediatr 1990; 36: 200.